Role of radiation therapy in a patient with primary pancreatic lymphoma

Clinical Lymphoma and Myeloma

Volumn 6, Issue 2, 2005, Pages 143-145

  Shahar, Karen H ^a   Carpenter, L Steven ^a   Jorgensen, Jeffrey ^a   Truong, Luan ^a   Baker, Kelty ^a   Teh, Bin S ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Chemotherapy; Combined modality treatment; Large cell lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL;

AGED; ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DRUG TOLERANCE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPHOMA; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS LYMPHOMA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; STENT; TREATMENT OUTCOME; TREATMENT RESPONSE; HISTIOCYTIC LYMPHOMA; INTENSITY MODULATED RADIATION THERAPY; MULTIMODALITY CANCER THERAPY; PANCREAS TUMOR; PATHOLOGY; RADIOGRAPHY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL; PANCREATIC NEOPLASMS; PREDNISONE; RADIOTHERAPY, INTENSITY-MODULATED; VINCRISTINE;

EID: 33644834455     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.042     Document Type: Article

References (18)

1. Hart MJ, White TT, Brown PC, et al. Potentially curable masses in the pancreas. Am J Surg 1987; 154:134-136.
2. Tuchek JM, DeJong SA, Pickleman J. Diagnosis, surgical intervention, and prognosis of primary pancreatic lymphoma. Am Surg 1993; 59:513-518.
3. Cooperman AM, Snady H, Bruckner HW, et al. Long term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy. Surg Clin N Am 2001; 81:699-708.
4. Islam S, Callery MP. Primary pancreatic lymphoma: A diagnosis to remember. Surgery 2001; 129:380-383.
5. Koniaris LG, Lillemoe KD, Yeo CJ, et al. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg 2000; 190:319-329.
6. Mauch P, Leonard R, Skarin A, et al. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphoma. J Clin Oncol 1985; 3:1301-1308.
7. Vijungco J. Stage I and II non-Hodgkin's lymphoma: results of regional radiation therapy. Am J Roentgenol Radium Ther Nucl Med 1973; 117:45-49.
8. Gordon LI, Harrington D, Andersen J, et al. Comparison of a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 1992; 327:1342-1349.
9. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328:1002-1006.
10. Horning SJ, Glick JH, Kim K et al. Final report of E1484: CHOP vs. CHOP + radiotherapy (RT) for limited stage diffuse aggressive lymphoma. Blood 2001; 98:724a (Abstract #3023).
11. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339:21-26.
12. Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993; 328:1023-1030.
13. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas 1994; 9:662-667.
14. Bouvet M, Staerkel GA, Spitz FR, et al. Primary pancreatic lymphoma. Surgery 1998; 123:382-390.
15. Jerusalem GH, Beguin YP. Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clin Lymphoma 2002; 3:56-61.
16. Lapela M, Leskinen S, Minn HR, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucase. Blood 1995; 86:3522-3527.
17. Delbeke D, Martin WH, Sandler MP, et al. Evaluation of benign vs. malignant hepatic lesions with positron emission tomography. Arch Surg 1998; 133:510-516.
18. Gupta N, Gill H, Graeber G, et al. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998; 114:1105-1111.